HK Stock MarketDetailed Quotes

02361 SINOHEALTH HLDG

Watchlist
  • 4.520
  • -0.010-0.22%
Not Open Nov 15 16:08 CST
2.04BMarket Cap19.40P/E (TTM)

SINOHEALTH HLDG Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
(FY)Dec 31, 2020
(Q9)Sep 30, 2020
(FY)Dec 31, 2019
Turnover
10.06%159.53M
11.08%396.19M
19.59%144.95M
10.03%356.67M
--121.21M
60.42%324.17M
66.32%240.43M
13.68%202.07M
--144.56M
8.13%177.75M
Operating income
10.06%159.53M
11.08%396.19M
19.59%144.95M
10.03%356.67M
121.21M
60.42%324.17M
66.32%240.43M
13.68%202.07M
144.56M
8.13%177.75M
Cost of sales
-1.40%-70.74M
12.57%-172.72M
-8.07%-69.77M
-50.20%-197.56M
---64.56M
-83.01%-131.53M
-65.13%-89.84M
-0.30%-71.87M
---54.41M
-13.14%-71.65M
Operating expenses
-1.40%-70.74M
12.57%-172.72M
-8.07%-69.77M
-50.20%-197.56M
-64.56M
-83.01%-131.53M
-65.13%-89.84M
-0.30%-71.87M
-54.41M
-13.14%-71.65M
Gross profit
18.10%88.79M
40.45%223.47M
32.71%75.18M
-17.41%159.11M
56.65M
47.95%192.64M
67.03%150.59M
22.72%130.21M
90.15M
4.99%106.1M
Selling expenses
-13.73%-17.18M
-2.37%-32.41M
-0.09%-15.11M
-27.74%-31.66M
---15.1M
-67.10%-24.79M
-81.49%-17.34M
-38.74%-14.83M
---9.55M
-38.63%-10.69M
Administrative expenses
-12.18%-16.96M
24.87%-34.64M
19.25%-15.12M
-4.41%-46.11M
---18.73M
-166.28%-44.16M
-170.03%-31.33M
-29.77%-16.59M
---11.6M
-1.39%-12.78M
Research and development expenses
-6.07%-28.88M
-1.12%-61.09M
4.53%-27.23M
-12.48%-60.41M
---28.52M
-34.88%-53.71M
-31.63%-38.38M
-36.08%-39.82M
---29.16M
-32.92%-29.26M
Impairment and provision
-6.79%-5.73M
-799.14%-24.08M
-425.07%-5.36M
6.20%-2.68M
---1.02M
-313.17%-2.86M
-79.53%-1.61M
46.97%-691K
---899K
-342.64%-1.3M
-Other impairment is provision
-6.79%-5.73M
-799.14%-24.08M
-425.07%-5.36M
6.20%-2.68M
---1.02M
-313.17%-2.86M
-79.53%-1.61M
46.97%-691K
---899K
-342.64%-1.3M
Operating interest expense
----
----
----
----
----
56.46%-532K
54.87%-412K
-112.15%-1.22M
---913K
-9.71%-576K
Special items of operating profit
-36.22%22.84M
9.53%40.13M
230.00%35.81M
24.82%36.64M
--10.85M
54.34%29.35M
62.29%20.63M
21.67%19.02M
--12.71M
4.84%15.63M
Operating profit
-11.00%42.87M
102.93%111.38M
1,063.53%48.17M
-42.79%54.89M
4.14M
26.12%95.95M
61.89%82.14M
13.35%76.07M
50.74M
-8.87%67.12M
Financing cost
-18.35%-329K
-55.34%-640K
-29.91%-278K
---412K
---214K
----
----
----
----
----
Share of profits of associates
----
----
----
----
----
---416K
---262K
----
----
----
Earning before tax
-11.17%42.54M
103.29%110.74M
1,119.87%47.89M
-42.98%54.47M
3.93M
25.58%95.53M
61.37%81.88M
13.35%76.07M
50.74M
-8.87%67.12M
Tax
78.74%-196K
-3,655.17%-9.8M
-167.74%-922K
98.89%-261K
--1.36M
-119.22%-23.55M
-187.80%-20.43M
15.65%-10.74M
---7.1M
-1.55%-12.74M
After-tax profit from continuing operations
-9.84%42.35M
86.19%100.94M
788.41%46.97M
-24.68%54.21M
5.29M
10.18%71.98M
40.81%61.45M
20.14%65.33M
43.64M
-11.01%54.38M
Earning after tax
-9.84%42.35M
86.19%100.94M
788.41%46.97M
-24.68%54.21M
5.29M
10.18%71.98M
40.81%61.45M
20.14%65.33M
43.64M
-11.01%54.38M
Minority profit
177.98%673K
29.32%-1.09M
-160.48%-863K
77.40%-1.55M
--1.43M
-163.19%-6.84M
-130.77%-5.84M
-51.87%-2.6M
---2.53M
-12.57%-1.71M
Profit attributable to shareholders
-12.87%41.68M
82.99%102.03M
1,139.20%47.83M
-29.25%55.76M
3.86M
16.03%78.81M
45.74%67.3M
21.10%67.93M
46.17M
-10.44%56.09M
Basic earnings per share
-9.09%0.1
76.29%0.2394
1,000.00%0.11
-35.70%0.1358
0.01
0.2112
27.02
Diluted earnings per share
-9.09%0.1
76.29%0.2394
1,000.00%0.11
-35.70%0.1358
0.01
0.2112
27.02
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021(FY)Dec 31, 2020(Q9)Sep 30, 2020(FY)Dec 31, 2019
Turnover 10.06%159.53M11.08%396.19M19.59%144.95M10.03%356.67M--121.21M60.42%324.17M66.32%240.43M13.68%202.07M--144.56M8.13%177.75M
Operating income 10.06%159.53M11.08%396.19M19.59%144.95M10.03%356.67M121.21M60.42%324.17M66.32%240.43M13.68%202.07M144.56M8.13%177.75M
Cost of sales -1.40%-70.74M12.57%-172.72M-8.07%-69.77M-50.20%-197.56M---64.56M-83.01%-131.53M-65.13%-89.84M-0.30%-71.87M---54.41M-13.14%-71.65M
Operating expenses -1.40%-70.74M12.57%-172.72M-8.07%-69.77M-50.20%-197.56M-64.56M-83.01%-131.53M-65.13%-89.84M-0.30%-71.87M-54.41M-13.14%-71.65M
Gross profit 18.10%88.79M40.45%223.47M32.71%75.18M-17.41%159.11M56.65M47.95%192.64M67.03%150.59M22.72%130.21M90.15M4.99%106.1M
Selling expenses -13.73%-17.18M-2.37%-32.41M-0.09%-15.11M-27.74%-31.66M---15.1M-67.10%-24.79M-81.49%-17.34M-38.74%-14.83M---9.55M-38.63%-10.69M
Administrative expenses -12.18%-16.96M24.87%-34.64M19.25%-15.12M-4.41%-46.11M---18.73M-166.28%-44.16M-170.03%-31.33M-29.77%-16.59M---11.6M-1.39%-12.78M
Research and development expenses -6.07%-28.88M-1.12%-61.09M4.53%-27.23M-12.48%-60.41M---28.52M-34.88%-53.71M-31.63%-38.38M-36.08%-39.82M---29.16M-32.92%-29.26M
Impairment and provision -6.79%-5.73M-799.14%-24.08M-425.07%-5.36M6.20%-2.68M---1.02M-313.17%-2.86M-79.53%-1.61M46.97%-691K---899K-342.64%-1.3M
-Other impairment is provision -6.79%-5.73M-799.14%-24.08M-425.07%-5.36M6.20%-2.68M---1.02M-313.17%-2.86M-79.53%-1.61M46.97%-691K---899K-342.64%-1.3M
Operating interest expense --------------------56.46%-532K54.87%-412K-112.15%-1.22M---913K-9.71%-576K
Special items of operating profit -36.22%22.84M9.53%40.13M230.00%35.81M24.82%36.64M--10.85M54.34%29.35M62.29%20.63M21.67%19.02M--12.71M4.84%15.63M
Operating profit -11.00%42.87M102.93%111.38M1,063.53%48.17M-42.79%54.89M4.14M26.12%95.95M61.89%82.14M13.35%76.07M50.74M-8.87%67.12M
Financing cost -18.35%-329K-55.34%-640K-29.91%-278K---412K---214K--------------------
Share of profits of associates -----------------------416K---262K------------
Earning before tax -11.17%42.54M103.29%110.74M1,119.87%47.89M-42.98%54.47M3.93M25.58%95.53M61.37%81.88M13.35%76.07M50.74M-8.87%67.12M
Tax 78.74%-196K-3,655.17%-9.8M-167.74%-922K98.89%-261K--1.36M-119.22%-23.55M-187.80%-20.43M15.65%-10.74M---7.1M-1.55%-12.74M
After-tax profit from continuing operations -9.84%42.35M86.19%100.94M788.41%46.97M-24.68%54.21M5.29M10.18%71.98M40.81%61.45M20.14%65.33M43.64M-11.01%54.38M
Earning after tax -9.84%42.35M86.19%100.94M788.41%46.97M-24.68%54.21M5.29M10.18%71.98M40.81%61.45M20.14%65.33M43.64M-11.01%54.38M
Minority profit 177.98%673K29.32%-1.09M-160.48%-863K77.40%-1.55M--1.43M-163.19%-6.84M-130.77%-5.84M-51.87%-2.6M---2.53M-12.57%-1.71M
Profit attributable to shareholders -12.87%41.68M82.99%102.03M1,139.20%47.83M-29.25%55.76M3.86M16.03%78.81M45.74%67.3M21.10%67.93M46.17M-10.44%56.09M
Basic earnings per share -9.09%0.176.29%0.23941,000.00%0.11-35.70%0.13580.010.211227.02
Diluted earnings per share -9.09%0.176.29%0.23941,000.00%0.11-35.70%0.13580.010.211227.02
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data